These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 6687124)

  • 21. [Regional right ventricular hypertrophy in hypertrophic cardiomyopathy and hypertension].
    Seo T; Yokota Y; Kumaki T; Takarada A; Kubo M; Kaku K; Toh S; Fukuzaki H
    J Cardiogr; 1985 Jun; 15(2):339-46. PubMed ID: 4093619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical ASH)].
    Koga Y; Takahashi H; Ifuku M; Itaya M; Adachi K; Toshima H
    J Cardiogr; 1984 Aug; 14(2):301-10. PubMed ID: 6543446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Left atrial booster pump function in patients with hypertrophic cardiomyopathy and essential hypertension: evaluations based on left atrial pressure-volume relationship].
    Sanada H; Shimizu M; Kita Y; Sugihara N; Shimizu K; Murakami T; Takeda R; Mifune J
    J Cardiol; 1992; 22(1):99-106. PubMed ID: 1307583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Noninvasive studies of dynamic left ventricular outflow obstruction in patients with sigmoid septum].
    Fukuda N; Asai M; Tominaga T; Irahara K; Mikawa T; Yamamoto M; Ohshima C; Kusaka Y; Oki T; Niki T
    J Cardiogr; 1984 Oct; 14(3):445-57. PubMed ID: 6152631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differentiation of hypertrophic cardiomyopathy from left ventricular hypertrophy induced by essential hypertension using magnetic resonance imaging].
    Doyoshita H; Murakami E; Takekoshi N; Matsui S; Nakato H; Enyama H
    J Cardiol; 1988 Mar; 18(1):113-9. PubMed ID: 2975702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of regional contractile dynamics and pathological findings of the left ventricular wall in patients with hypertrophic cardiomyopathy].
    Usuki S; Yokota Y; Maehashi N; Nakanishi M; Nakanishi O; Emoto R; Kurozumi H; Miki T; Fukuzaki H; Ito H
    J Cardiol; 1988 Sep; 18(3):665-72. PubMed ID: 3249283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Left ventricular ejection and ejection reserve during isoproterenol infusion in hypertrophic obstructive cardiomyopathy (author's transl)].
    Ensslen R; Schwarz F; Thormann J; Schlepper M
    Z Kardiol; 1977 Nov; 66(11):633-40. PubMed ID: 145761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac hypertrophy in hypertrophic cardiomyopathy and hypertension evaluated by echocardiography and body surface isopotential mapping.
    Yoshida H; Imataki K; Nagahana H; Ihoriya F; Nakao Y; Saito D; Haraoka S
    J Cardiogr; 1986 Jun; 16(2):399-406. PubMed ID: 2953823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Left ventricular function in patients with right ventricular overload evaluated by exercise echocardiography: comparison of pulmonary hypertension and atrial septal defects].
    Ishimoto T; Asai M; Tominaga T; Ohkushi H; Taoka M; Ohshima C; Fukuda N; Oki T; Niki T; Mori H
    J Cardiogr; 1984 Oct; 14(3):521-35. PubMed ID: 6536682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of beta-blockers and Ca antagonists on diastolic function of the hypertrophied left ventricle: an echocardiographic study].
    Isobe M; Kashida M; Isshiki T; Koizumi K; Kuwako K; Umeda T; Yamaguchi T; Machii K; Suzuki K; Tohda E
    J Cardiogr; 1982 Dec; 12(4):939-52. PubMed ID: 6136549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Time constant of the left ventricular pressure fall, and onset and rate of expansion of the left ventricular segment in hypertrophic cardiomyopathy].
    Osato S; Ishikawa K; Kanamasa K; Ogai T; Oda A; Katori R
    J Cardiol; 1987 Sep; 17(3):489-95. PubMed ID: 3453845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
    Senn M; Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Doppler and echocardiographic assessments of effects of disopyramide on non-obstructive hypertrophic cardiomyopathy].
    Nagashima J
    J Cardiol; 1991; 21(1):75-86. PubMed ID: 1817183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of regional hypertrophy in hypertrophic cardiomyopathy with ECG triggered nuclear magnetic resonance tomography--comparison with hypertensive patients and persons with healthy hearts].
    Schneider R; Köhler D; Berghöfer G; Paeprer H; Felix R; Thormann I; Schörner W; Schmutzler H
    Z Kardiol; 1985 Mar; 74(3):144-51. PubMed ID: 3158127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Complex hemodynamic analysis of left ventricular systole in hypertrophic cardiopathy--clinical implications].
    Dabrowski M; Górecka B; Witkowski A; Ruzyłło W
    Kardiol Pol; 1990; 33(5):288-302. PubMed ID: 2074625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indices of left ventricular systolic function derived by computer analysis of digitised M-mode echocardiograms.
    Bett JH; Dryburgh LG; Boyle CM
    Herz; 1985 Apr; 10(2):120-4. PubMed ID: 4039291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global and regional abnormalities of left ventricular diastolic filling in hypertrophic cardiomyopathy.
    Inoue T; Morooka S; Hayashi T; Takayanagi K; Sakai Y; Fujito T; Fujinuma S; Takabatake Y
    Clin Cardiol; 1991 Jul; 14(7):573-7. PubMed ID: 1747967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Left ventricular short-axis plane for magnetic resonance imaging: its clinical importance and applications].
    Suzuki J; Sakamoto T; Kawakubo K; Hada Y; Amano K; Takenaka K; Hasegawa I; Shiota T; Sugimoto T; Nishikawa J
    J Cardiol; 1987 Jun; 17(2):249-58. PubMed ID: 3448166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathophysiology of asymmetric septal hypertrophy with special reference to the response to isoproterenol administration].
    Iida K; Sugishita Y; Matsuda M; Yamaguchi T; Ajisaka R; Matsumoto R; Fujita T; Ito I
    J Cardiogr; 1984 Jun; 14(1):85-93. PubMed ID: 6240510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.